492 related articles for article (PubMed ID: 27165003)
21. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein.
Fei P; Yin J; Wang W
Cell Cycle; 2005 Jan; 4(1):80-6. PubMed ID: 15611632
[TBL] [Abstract][Full Text] [Related]
22. Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.
Thompson ER; Doyle MA; Ryland GL; Rowley SM; Choong DY; Tothill RW; Thorne H; ; Barnes DR; Li J; Ellul J; Philip GK; Antill YC; James PA; Trainer AH; Mitchell G; Campbell IG
PLoS Genet; 2012 Sep; 8(9):e1002894. PubMed ID: 23028338
[TBL] [Abstract][Full Text] [Related]
23. The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC.
Léveillé F; Ferrer M; Medhurst AL; Laghmani el H; Rooimans MA; Bier P; Steltenpool J; Titus TA; Postlethwait JH; Hoatlin ME; Joenje H; de Winter JP
DNA Repair (Amst); 2006 May; 5(5):556-65. PubMed ID: 16513431
[TBL] [Abstract][Full Text] [Related]
24. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract][Full Text] [Related]
25. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.
Esteban-Jurado C; Vila-Casadesús M; Garre P; Lozano JJ; Pristoupilova A; Beltran S; Muñoz J; Ocaña T; Balaguer F; López-Cerón M; Cuatrecasas M; Franch-Expósito S; Piqué JM; Castells A; Carracedo A; Ruiz-Ponte C; Abulí A; Bessa X; Andreu M; Bujanda L; Caldés T; Castellví-Bel S
Genet Med; 2015 Feb; 17(2):131-42. PubMed ID: 25058500
[TBL] [Abstract][Full Text] [Related]
26. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.
Couch FJ; Johnson MR; Rabe K; Boardman L; McWilliams R; de Andrade M; Petersen G
Cancer Res; 2005 Jan; 65(2):383-6. PubMed ID: 15695377
[TBL] [Abstract][Full Text] [Related]
27. FANCC Dutch founder mutation in a Mennonite family from Tamaulipas, México.
García-de Teresa B; Frias S; Molina B; Villarreal MT; Rodriguez A; Carnevale A; López-Hernández G; Vollbrechtshausen L; Olaya-Vargas A; Torres L
Mol Genet Genomic Med; 2019 Jun; 7(6):e710. PubMed ID: 31044565
[TBL] [Abstract][Full Text] [Related]
28. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
29. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.
Chubb D; Broderick P; Frampton M; Kinnersley B; Sherborne A; Penegar S; Lloyd A; Ma YP; Dobbins SE; Houlston RS
J Clin Oncol; 2015 Feb; 33(5):426-32. PubMed ID: 25559809
[TBL] [Abstract][Full Text] [Related]
30. Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.
Keupp K; Hampp S; Hübbel A; Maringa M; Kostezka S; Rhiem K; Waha A; Wappenschmidt B; Pujol R; Surrallés J; Schmutzler RK; Wiesmüller L; Hahnen E
Mol Genet Genomic Med; 2019 Sep; 7(9):e863. PubMed ID: 31347298
[TBL] [Abstract][Full Text] [Related]
31. Risk of cancer in heterozygous relatives of patients with Fanconi anemia.
McReynolds LJ; Giri N; Leathwood L; Risch MO; Carr AG; Alter BP
Genet Med; 2022 Jan; 24(1):245-250. PubMed ID: 34906449
[TBL] [Abstract][Full Text] [Related]
32. A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.
Fierheller CT; Guitton-Sert L; Alenezi WM; Revil T; Oros KK; Gao Y; Bedard K; Arcand SL; Serruya C; Behl S; Meunier L; Fleury H; Fewings E; Subramanian DN; Nadaf J; Bruce JP; Bell R; Provencher D; Foulkes WD; El Haffaf Z; Mes-Masson AM; Majewski J; Pugh TJ; Tischkowitz M; James PA; Campbell IG; Greenwood CMT; Ragoussis J; Masson JY; Tonin PN
Genome Med; 2021 Dec; 13(1):186. PubMed ID: 34861889
[TBL] [Abstract][Full Text] [Related]
33. Molecular defects identified by whole exome sequencing in a child with Fanconi anemia.
Zheng Z; Geng J; Yao RE; Li C; Ying D; Shen Y; Ying L; Yu Y; Fu Q
Gene; 2013 Nov; 530(2):295-300. PubMed ID: 23973728
[TBL] [Abstract][Full Text] [Related]
34. RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families.
Blanco A; Gutiérrez-Enríquez S; Santamariña M; Montalban G; Bonache S; Balmaña J; Carracedo A; Diez O; Vega A
Breast Cancer Res Treat; 2014 Aug; 147(1):133-43. PubMed ID: 25086635
[TBL] [Abstract][Full Text] [Related]
35. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
[TBL] [Abstract][Full Text] [Related]
36. Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.
Cheung RS; Taniguchi T
Int J Hematol; 2017 Sep; 106(3):335-344. PubMed ID: 28631178
[TBL] [Abstract][Full Text] [Related]
37. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M.
Meetei AR; Medhurst AL; Ling C; Xue Y; Singh TR; Bier P; Steltenpool J; Stone S; Dokal I; Mathew CG; Hoatlin M; Joenje H; de Winter JP; Wang W
Nat Genet; 2005 Sep; 37(9):958-63. PubMed ID: 16116422
[TBL] [Abstract][Full Text] [Related]
38. A Case Report of Germline Compound Heterozygous Mutations in the
Kwong A; Ho CYS; Shin VY; Au CH; Chan TL; Ma ESK
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477375
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer and Fanconi anemia: what are the connections?
Zdzienicka MZ; Arwert F
Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
[TBL] [Abstract][Full Text] [Related]
40. Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer.
Mantere T; Haanpää M; Hanenberg H; Schleutker J; Kallioniemi A; Kähkönen M; Parto K; Avela K; Aittomäki K; von Koskull H; Hartikainen JM; Kosma VM; Laasanen SL; Mannermaa A; Pylkäs K; Winqvist R
Clin Genet; 2015 Jul; 88(1):68-73. PubMed ID: 24989076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
